國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

The role of institutional incentives...

Rye, Colleen Beecken.

The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies.
作者:	Rye, Colleen Beecken.
面頁冊數:	153 p.
附註:	Source: Dissertation Abstracts International, Volume: 70-06, Section: A, page: 2141.
附註:	Adviser: John R. Kimberly.
Contained By:	Dissertation Abstracts International70-06A.
標題:	Business Administration, Management.
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3363590
ISBN:	9781109236392

The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies.
Rye, Colleen Beecken.

The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies. - 153 p.

Source: Dissertation Abstracts International, Volume: 70-06, Section: A, page: 2141.

Thesis (Ph.D.)--University of Pennsylvania, 2009.

Although research shows that nonpecuniary incentives can help stimulate both innovative output and firm-level productivity in R&D-intensive settings, organizations have difficulty creating and implementing these kinds of incentives, partly because the underlying social processes involved in offering them have yet to be elucidated. In this dissertation, I develop a new theoretical concept, "institutional incentives." This concept emerged as I conducted a field-based study of resource allocation processes in complex organizational settings. I explain how managers in biopharmaceutical firms create and implement institutional incentives, embedding them in firm-level processes.

ISBN: 9781109236392Subjects--Topical Terms:

212493
Business Administration, Management.

The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies.
LDR:03262nmm 2200301 4500 001 240225
005 20100310090825.5
008 100410s2009 ||||||||||||||||| ||eng d
020 $a 9781109236392
035 $a (UMI)AAI3363590
035 $a AAI3363590
040 $a UMI $c UMI
100 1 $a Rye, Colleen Beecken. $3 384251
245 1 4 $a The role of institutional incentives in the resource allocation processes of pharmaceutical and biotechnology companies.
300 $a 153 p.
500 $a Source: Dissertation Abstracts International, Volume: 70-06, Section: A, page: 2141.
500 $a Adviser: John R. Kimberly.
502 $a Thesis (Ph.D.)--University of Pennsylvania, 2009.
520 $a Although research shows that nonpecuniary incentives can help stimulate both innovative output and firm-level productivity in R&D-intensive settings, organizations have difficulty creating and implementing these kinds of incentives, partly because the underlying social processes involved in offering them have yet to be elucidated. In this dissertation, I develop a new theoretical concept, "institutional incentives." This concept emerged as I conducted a field-based study of resource allocation processes in complex organizational settings. I explain how managers in biopharmaceutical firms create and implement institutional incentives, embedding them in firm-level processes.
520 $a In the course of my research, I collected interview data from nine biopharmaceutical firms and archival data from public and private sources. Based on my analysis of these data, I found that commercial research scientists think of their employment as an opportunity to fulfill the objectives embedded in their shared norms and values. Some firms in my sample make it clear to these values-oriented employees---through specific coordinated actions---that the firm is committed to operating in ways that enable employees to fulfill these objectives. Commercial research scientists are motivated to work harder and more creatively in these firms, and these firms are better able to attract and retain commercial research scientists. By acting in ways that enable employees to fulfill the objectives embedded in their norms and values, employers offer their scientists "institutional incentives."
520 $a I present one approach to analyzing institutional incentives: connect a focal group's system of values and norms to coordinated organizational activities to understand if and how managers create and implement institutional incentives in their firms (or fail to do so). To this end, I explicate several norms and values uncovered in the field settings. I then elaborate three categories of practices by which managers create and implement institutional incentives in the field settings. Finally, I connect specific practices to the values and norms they activate, thereby showing how institutional incentives "work." I close by suggesting the implications of these findings for several conversations in the literature.
590 $a School code: 0175.
650 4 $a Business Administration, Management. $3 212493
650 4 $a Health Sciences, Health Care Management. $3 212791
690 $a 0454
690 $a 0769
710 2 $a University of Pennsylvania. $3 212781
773 0 $t Dissertation Abstracts International $g 70-06A.
790 1 0 $a Kimberly, John R., $e advisor
790 $a 0175
791 $a Ph.D.
792 $a 2009
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3363590